• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3321 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Benzodiazepines for the treatment of post traumatic stress disorder: a review of the clinical effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Descemet stripping automated endothelial keratoplasty: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Hyperbaric oxygen therapy for autism: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Casting for foot orthotics: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for mood disorders: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for adults with axis II disorders: a review of clinical effectiveness
2009     Institute for Clinical Evaluative Sciences (ICES) Blood glucose test strip use: patterns, costs and potential cost reduction associated with reduced testing
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for anxiety: a review of the clinical effectiveness
2009     Institute for Clinical Evaluative Sciences (ICES) What does it take to make a healthy province? A benchmark study of jurisdictions in Canada and around the world with the highest levels of health and the best health behaviours
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy in the treatment of schizophrenia: a review of the clinical effectiveness
2009     Medical Advisory Secretariat (MAS) Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses
2009     Institute for Clinical Evaluative Sciences (ICES) Registry of the Canadian Stroke Network. Report on the 2004/05 Ontario Stroke Audit
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pathogen reduction technologies for blood products: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Lithotripsy for kidney stones or gallstones: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Addendum to the Canadian Agency for Drugs and Technologies in Health guidelines for the economic evaluation of health technologies: specific guidance for oncology products
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Aortoiliofemoral arteriogram-guided peripheral vascular stenting: a review of the clinical and cost-effectiveness
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Reuse of single use medical devices]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Radioimmunotherapies for non-hodgkin lymphoma: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Endovascular coiling versus surgical clipping: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated Factor VII in treatment of hemorrhage unrelated to hemophilia: a systematic review and economic evaluation
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Carotid artery stenting versus carotid endarterectomy: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Drugs for pulmonary arterial hypertension: a systematic review of the clinical-effectiveness of combination therapy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Elective endovascular abdominal aortic aneurism repair versus open surgery: a review of the clinical and cost-effectiveness
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) [The use of carmustine implants (Gliadel wafers) in patients with malignant glioma]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization of foot care instruments: a review of the guidelines
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Curative treatment for esophageal cancer: systematic review of neoadjuvant therapy and chemoradiotherapy alone: summary]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous immunoglobulin for chronic inflammatory demyelinating polyneuropathy: Clinical- and cost-effectiveness analyses
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Universal, community-based developmental screening tools for children 6 years and younger: a review of clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Resin-bonded fixed bridges and conventional fixed bridges: a review of the advantages and disadvantages and indications
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Foot care for patients with peripheral vascular disease: a review of the guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Urine based testing for gonorrhea and chlamydia: a review of diagnostic accuracy, cost-effectiveness, and compliance
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Naltrexone for the treatment of alcohol dependence in individuals with co- dependencies: a review of the clinical effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Naltrexone in combination with acamprosate for the treatment of alcohol dependence: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Organic acid testing for autism: a review of the diagnostic accuracy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Low molecular weight heparins versus unfractionated heparin for thromboprophylaxis: a review of the cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Intraperitoneal chemotherapy for ovarian cancer patients: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Celecoxib for post-operative pain management: a review of the clinical benefit and harm
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Indirect evidence: indirect treatment comparisons in meta-analysis
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral care sponges for long-term care patients: a review of the clinical-effectiveness
2009     Institute of Health Economics (IHE) Human papillomavirus (HPV) testing in Alberta
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable ultrasonography in small emergency departments: a systematic review of the guidelines and clinical-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Botulinum toxin A for the treatment of trigeminal neuralgia and temporomandibular joint dysfunction: a review of the clinical-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pelvic floor repair systems: a review of the clinical-effectiveness, cost- effectiveness, and guidelines
2009     Institute of Health Economics (IHE) Effectiveness of organizational interventions for the prevention of stress in the workplace
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Botulinum toxin A for headaches in adults: a review of clinical-effectiveness and safety
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Australian sheepskins for the management of pressure ulcers: a review of the clinical-effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of lidocaine on adults with open wounds: a review of the safety
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Methadone for the management of pain in patients with opioid addiction: a review of the evidence and guidelines for dosing recommendations
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Speech and language therapy for children of preschool age: a review of the clinical-effectiveness and quality of life
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Specifications of endosseous dental implants: a review of the advantages, disadvantages, and success rates
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Morphogenetic bone for fracture healing: a review of the clinical-effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pre-operative screening for Methicillin-Resistant Staphylococcus aureus (MRSA) infection: a review of the clinical-effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) At home, pre-operative skin preparation: a review of the clinical-effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Rapid response testing for the detection of clostridium difficile: a review of the diagnostic accuracy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Metal-ceramic and porcelain dental crowns: a review of clinical and cost- effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Endovenous laser therapy for varicose veins: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Microprocessor-controlled prosthetic knees (C-Leg) for patients with above-knee amputations: a review of the clinical- and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Vasopressin as first-line therapy for cardiac arrest: a review of the guidelines and clinical-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Devices for endometrial ablation therapy in the outpatient setting: clinical- and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fluoridated water for cavity prevention: a review of the clinical-effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Levothyroxine for solid organ donors: a review of the clinical-effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Quality assessment of the Canadian Thoracic Society guidelines for sleep disordered breathing in adults
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Botulinum toxin A for the management of pelvic pain and urinary incontinence in women: a review of the clinical-effectiveness and safety
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-nuclear medicine imaging technologies for cardiology: a review of alternatives to nuclear medicine imaging
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Diagnostic uses of technetium-99m: clinical conditions
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Diagnosis of snoring and obstructive sleep apnea: a review of the accuracy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral appliances for treatment of snoring and obstructive sleep apnea: a review of clinical-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of topical anesthetics for suturing and circumcisions in pediatric patients: a review of clinical effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Programs to manage aggressive behaviour in long-term care patients: a review of clinical-effectiveness, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care testing for streptococcal sore throat: a review of diagnostic accuracy, cost-effectiveness, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Magnetic resonance imaging for patients with cardiomyopathy: a review of the clinical-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Endobronchial ultrasound for lung cancer diagnosis and staging: a review of the clinical- and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Magnetic resonance imaging for patients with valvular heart disease: a review of clinical-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical tests for colorectal cancer screening of average risk individuals: a systematic review of accuracy and compliance
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care HIV testing: a review of the clinical and cost-effectiveness and diagnostic accuracy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography: a review of the risk of cancer associated with radiation exposure
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Acupuncture for managing chronic shoulder and lower back pain: a review of optimal frequency
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumors of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Subcutaneous administration of proton pump inhibitors in palliative care patients: a review of clinical effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Subcutaneous lidocaine in community care: a review of the guidelines and patient safety
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Managing crohn's disease in adults: a summary of the guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Dabigatran or Rivaroxaban versus other anticoagulants for thromboprophylaxis after major orthopedic surgery: systematic review of comparative clinical-effectiveness and safety
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Gliclazide MR versus glyburide for management of type 2 diabetes: a review of the clinical effectiveness and safety
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sharp and round optic edges of intraocular lenses: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Dialectical Behavior Therapy in adolescents for suicide prevention: Systematic review of clinical-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Hypertonic saline nebules for patients with cystic fibrosis and bronchioectasis: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable monitoring devices for diagnosis of obstructive sleep apnea at home: review of accuracy, cost effectiveness, guidelines, and coverage in Canada
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Naltrexone for the treatment of alcohol dependence: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral endotracheal tube placement in neonates, pediatric, and adult patients: a review of the guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of hydromyelia in adults: a review of clinical effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Reassessment of health technologies: obsolescence and waste
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Surgical dental interventions for use in children and adults: a review of the comparative clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Development and testing of search filters to identify economic evaluations in MEDLINE and EMBASE
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Cardiac Magnetic Resonance Imaging (MRI) for patients with coronary artery disease: a review of diagnostic accuracy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-Acting Beta2-Agonist and Inhaled Corticosteroid Combination Therapy for Adult Persistent Asthma: Systematic Review of Clinical Outcomes and Economic Evaluation
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Multi-slice computed tomography coronary angiography for coronary artery disease: a review of the clinical effectiveness and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Follow-up to 'The role of pharmacologic management in neovascular age- related macular degeneration: clinical and cost-effectiveness'